Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at San Francisco, California
Dates
study started
completion around
Principal Investigator
by Parya Saberi, PharmD
Headshot of Parya Saberi
Parya Saberi

Description

Summary

This study will support the expansion of long-acting injectable antiretroviral therapy (LAI-ART) in non-clinical settings by developing, implementing, and evaluating a comprehensive, theory-informed training intervention to support the administration of LAI-ART by a trained layperson injector (e.g., friend, family, partner identified by a person living with HIV). This study will address barriers to LAI-ART uptake and persistence, enhance real-world effectiveness, and help close critical HIV care gaps.

Details

Keywords

HIV Infections, HIV, Long-acting injectable antiretroviral therapy (LAI-ART), INVITE-Home, Clinic-Administered LAI-ART, Oral ART, Home-Based LAI-ART Administration, Clinic-Based LAI-ART Administration, Oral ART Administration

Eligibility

Location

  • Division of Prevention Science, Center for AIDS Prevention Studies (CAPS)
    San Francisco California 94143 United States

Lead Scientist at UCSF

  • Parya Saberi, PharmD
    Parya Saberi, PharmD, MAS, MFA, AAHIVP is an Associate Professor at the Division of Prevention Science in the Department of Medicine at the University of California, San Francisco (UCSF) and the Director of the UCSF Center for AIDS Prevention Studies Developmental Core. Dr. Saberi is funded by the National Institutes of Health and the Centers for Disease Control and Prevention.

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT06488846
Study Type
Observational
Participants
Expecting 1000 study participants
Last Updated